A glance at the wrist replaces a reach for the phone
For decades, insulin-dependent diabetics have structured their lives around a small, painful ritual — the finger prick — and the number it yields. Now, through a partnership between wearable technology and medical sensing, that number can appear on a wrist without a phone nearby, without a test strip, without the reach and the wait. Dexcom's updated G7 app quietly redraws the boundary between medical device and everyday object, offering millions of people a glimpse of the frictionless monitoring Apple imagined nearly a decade ago but has yet to fully deliver.
- Millions of insulin-dependent diabetics face daily finger pricks, expensive test strips, and the ever-present risk of dangerous dosing errors that can cause unconsciousness, organ failure, or amputation.
- Apple promised non-invasive glucose monitoring on the original Watch in 2015, but the science refused to cooperate — leaving a decade-long gap between vision and reality.
- Dexcom has stepped into that gap with a software update to its G7 app, enabling the Apple Watch to receive blood glucose readings directly from the under-skin sensor via Bluetooth, no iPhone required.
- The feature works on Apple Watch Series 6 or later running watchOS 10, and activates automatically once the iPhone app is updated — a low-friction path to a meaningful clinical upgrade.
- The sensor still requires insertion under the skin, so this is not the non-invasive breakthrough Apple is still chasing — but for daily life, a glance at the wrist now replaces a reach for the phone.
For millions of people who depend on insulin to survive, blood glucose monitoring has meant the same painful routine for decades — a lancet, a test strip, a glucometer, a number. That number dictates how much insulin to inject before every meal, and the stakes of getting it wrong are severe: too much insulin can cause loss of consciousness, too little leads over time to organ damage, vision loss, and amputation.
Apple recognized the weight of this burden nearly a decade ago, reportedly planning non-invasive glucose monitoring for the original Apple Watch in 2015. The technology never arrived. Year after year, the feature remained a promise deferred.
Dexcom has now offered a different answer. Its G7 continuous glucose monitor — a small sensor worn under the skin — has long transmitted readings wirelessly to an iPhone. A software update to version 2.2.1 changes the architecture: the Apple Watch is now a third connected device, receiving glucose data directly from the sensor via Bluetooth, with no iPhone required nearby. For users with a Series 6 or later watch running watchOS 10, the update pushes automatically and the connection establishes itself.
This is not the non-invasive future Apple envisioned. The sensor still requires insertion. But for people managing a chronic condition that demands constant attention, the difference between glancing at a wrist and reaching for a phone is not trivial — it is a small liberation from the friction of daily vigilance. Apple continues its work on true non-invasive monitoring, still on the horizon. In the meantime, Dexcom has made the present a little more livable.
For millions of people who depend on insulin to survive, the daily ritual of blood testing has remained largely unchanged for decades. A lancet punctures the skin. A drop of blood lands on a test strip. The strip slides into a glucometer. A number appears. This happens at least three times a day, every day, because that number—the blood glucose reading—determines how much insulin needs to be injected before eating. Get it wrong and the consequences are severe: too much insulin triggers hypoglycemia, which can cause loss of consciousness; too little, and over time, the disease ravages organs, damages eyesight, and can necessitate amputation of limbs. The pain of repeated finger pricks is real, but it pales beside the cost: test strips are disposable, expensive, and add up quickly across a lifetime of management.
Apple has been chasing a solution to this problem for nearly a decade. The company reportedly planned to include non-invasive blood glucose monitoring on the original Apple Watch in 2015, imagining a future where diabetics could simply glance at their wrist for a reading. The technology didn't cooperate. Year after year, the feature remained out of reach, still in development, still promised but not delivered.
Now, a different path has opened. Dexcom, a medical device manufacturer, has built what Apple could not—at least not yet. The company's G7 continuous glucose monitor is a small sensor placed under the skin, typically on the arm, that transmits blood sugar readings wirelessly. For years, it sent those readings to an iPhone. Diabetics using insulin pumps could receive the data there too, allowing the pump to automatically dispense the correct dose. But the system still required the phone to be present, still tethered users to a device in their pocket.
With a software update to version 2.2.1, Dexcom has fundamentally changed the equation. The G7 app now treats the Apple Watch as a third connected device, communicating directly with the sensor via Bluetooth. A diabetic can now see their glucose reading on their wrist without the iPhone anywhere nearby. The watch becomes, in effect, a standalone glucose monitor—the closest thing yet to the seamless, non-invasive monitoring that Apple envisioned a decade ago.
The technical requirements are modest but specific. You need an Apple Watch Series 6 or later, running watchOS 10 or earlier. The Dexcom app on your iPhone must be updated to the new version, which automatically pushes the corresponding app to the watch. From there, the connection is direct: sensor to watch, no intermediary required.
This is not the solution Apple promised. It is not non-invasive; the sensor still requires insertion under the skin. But it is a meaningful step forward for the millions of people who live with insulin-dependent diabetes. The pain of finger pricks remains, but the friction of managing readings throughout the day has been reduced. A glance at the wrist replaces a reach for the phone. The phone no longer needs to be in the room. For people managing a chronic condition that demands constant attention, that small liberation matters.
Apple continues its work on true non-invasive glucose monitoring, a feature that remains perpetually on the horizon. But while the company waits for the science to catch up to the vision, Dexcom has delivered something real: a way to make the existing technology less intrusive, less burdensome, and more integrated into the devices people already wear.
Citas Notables
Too much insulin triggers hypoglycemia and loss of consciousness; too little damages organs, eyesight, and can necessitate amputation— Medical consequence of incorrect insulin dosing
La Conversación del Hearth Otra perspectiva de la historia
Why did it take so long for this to reach the Apple Watch? Dexcom had the sensor working years ago.
The bottleneck was always the connection architecture. The sensor was designed to talk to a phone first. Making it talk directly to a watch required rethinking the whole Bluetooth handshake, the power consumption, the data flow. It's not trivial.
But Apple Watch has been around since 2015. Why didn't Dexcom do this sooner?
Partly because the market didn't demand it yet. Most people with the G7 were fine checking their phone. But as wearables became more central to daily life, the friction of needing the phone nearby became more obvious. Dexcom saw the opportunity.
Does this mean Apple has given up on non-invasive glucose monitoring?
Not at all. But there's a difference between what's theoretically possible and what's practically manufacturable at scale. Apple's been working on this since at least 2015. The science is hard. Meanwhile, Dexcom solved a different problem: making the existing sensor work better with the devices people already own.
For a diabetic, what actually changes in their day-to-day life?
The phone stays in your pocket. You check your wrist instead. No more fumbling for your phone to see if your blood sugar is dropping. It sounds small, but when you're managing something three times a day, every day, small frictions add up. This removes one of them.
Is this a permanent solution, or a stopgap?
It's a stopgap. The real endgame is non-invasive monitoring—no sensor insertion at all. But stopgaps matter when you're living with a chronic condition. This one buys time and improves the present while the future gets built.